Titles

1. A.E.O.Otedo,  S.O Mc Ligeyo, F.A. Okoth and J.K. Kayima. Sero-prevalence of Hepatitis B and C in maintenance dialysis patients in a public hospital in Kenya. S.A.M.J, 2003, May; 93;[5]: 380-384.

2.  Birgitte JV, Lee Corl Kenty, Anthony E. Butterworth, Curtis H, kariuki, Hilda Kadzo, Amos Otedo, Et al. detailed clinical and ultrasound examination of children and adolescents in a Schistosoma endemic area in Kenya: Hepatosplenic disease in the absence of portal fibrosis: Trop. Med. And Int. health 2004;[9]:(4): 1-10

3.  A.E.O. Otedo. Halothane induced hepatitis. EAMJ 2004;[81]: (10): 538-539.

4.   A.E.O. Otedo. HBV, HIV co-infection at Kisumu District Hospital, Kenya. EAMJ 2004;[81](12):626-630.

5.    Mark Booth, Birgitte J.V, Anthony EB., Henry C kariuki , Clifford Amaganga, Amos Otedo, John H. Ouma et al. Exposure to malaria affects the regression of hepatosplenomegally after treatment for Schistosoma Mansoni infection in Kenyan children. BMC Medicine 2004; [2]: (360):1-10

6.   Booth M., Vennervald BJ., Kenty LC., Butterworth AE., Kariuki CH., Amos Otedo, kadzo H., et al. Microgeographical varaiation in exposure to Schistosoma Mansoni and Malaria and exercabation  of splenomegally in Kenyan school aged children. BMC Infectious Diseases 2004; [14] :1-11

7.  A.E.O. Otedo, Oyoo G.O., Obondi JO., and Otieno CF.Vasculitis in HIV; A report of eight cases.EAMJ 2005,Decv[82];(12):656-659.

8.   Lut van damme, Awango Agot et al. Multicentre, double blind, placebo controlled study to assess the safety and effectiveness of daily  Truvada in preventing HIV infection in Women at risk- Kenya site Bondo site- CROI

9.   A.E.O. Otedo, C.F. Otieno, C. Okal, D. Othero, G.O. Oyoo and E. Omonge. Morbidity and CD4+ cell counts at initial presentation of a cohort of HAART-naive HIV positive Kenyan patients: implications to initiating HAART. EAMJ, DEC. 2013 (SUPPL.) [90]; (12): S3-14

10.    C.F. Otieno, A.E.O. Otedo, D. Othero, M.Y. Otiende, P. Okoth, Omonge and G.O. Oyoo. CD4+ cell response to anti-retroviral therapy (ARTS) in routine clinical care over one year period in a cohort of HAART-naive, HIV positive Kenyan patients.  EAMJ, DEC. 2013 (SUPPL.) [90]; (12): S15-S24.

11.  A.E.O. Otedo, J.O., Obondi, C.F. Otieno and G.O. Oyoo. Cholangiopathy in a cohort of HIV positive Kenyan patients: EAMJ, DEC. 2013 (SUPPL.) [90]; (12): S25-S32.

12.   A.E.O. Otedo, C.F. Otieno, J. Jowi, G.O. Oyoo and E. Omonge.  Cryptococcous meningitis in a cohort of HIV positive Kenyan patients: Outcome after two weeks of therapy. EAMJ, DEC. 2013 (SUPPL.) [90]; (12): S33-S39.

13.   A.E.O. Otedo, C.F. Otieno, G.O. Oyoo and E. Omonge. Anti-retroviral related liver injury (ARLI): A series of 11 cases. EAMJ, DEC. 2013 (SUPPL.) [90]; (12): S40-S47.

14.   A.E.O Otedo, G.O. Oyoo, J.O. Otieno, C.F. Otieno and E. Omonge. Pyomyositis in HIV: A series of 12 cases. EAMJ, DEC. 2013 (SUPPL.) [90]; (12): S48-S52.

15.    C.F. Otieno, A.E.O. Otedo, G.O. Oyoo and E. Omonge. Diabetes mellitus/HIV interphase. A series of 10 cases.  EAMJ, DEC. 2013 (SUPPL.) [90]; (12): S53-S56.

16.    C.F. Otieno, A.E.O. Otedo, M.Y. Otiende, Omonge and G.O. Oyoo. Reasons for change of anti-retroviral therapy (ART) drugs: Local experience. EAMJ, DEC. 2013 (SUPPL.) [90]; (12): S57-S61.

17.    E.O.Omonge, C.F. Otieno, M.C. Maritim, C.S. Ilovi, L. Achieng and A.E.O. Otedo. Osteopenia and osteonecrosis in HIV infection: Report of two cases. EAMJ, DEC. 2013 (SUPPL.) [90]; (12): S75-S78.

18.   E.O.Omonge, C.F. Otieno, M.C. Maritim, C.S. Ilovi, L. Achieng and A.E.O. Otedo. Unboosted atzanavir in treatment of HIV infection: Consideration of tolerability and safety while maintaining efficacy: Report of two cases. EAMJ, DEC. 2013 (SUPPL.) [90]; (12): S79-S82.

19. Guidelines for the treatment of chronic Hepatitis B and C viral infections in Kenya, 2015.  (Editorial board member)

20. *Otedo A.E.O., Estambale Benson, Omollo Ongati and Simbiri Ken. Liver (hepatocellular) cancer in HIV positive patients in Kenya. ( presented the paper at 11th African medical Association of Sciences, Hilton, Nairobi, Kenya)-2015, November.

21. *Otedo A.E.O., Estambale Benson, Omolo Ongati and Simbiri Kenneth. Modeling of liver cancer risk factors and dynamics at community level. AMS Sept. 2017, 11; [57]: 2707-2726.

22. *Otedo A.E.O., Estambale Benson, Omolo Ongati and Simbiri Kenneth. Mathematical modelling of liver cancer in Western Kenya. AMS Nov. 2017, 11; [58]: 2855-2875

Contact Information
Dr. Amos E. O. Otedo
Lake Clinical Centre
Wedco Centre, Shop Unit 1 Block C, Jomo Kenyatta Highway
P.O. Box 4685,  KISUMU 40103
KENYA
Office:  +254 57 23434  | Mobile: +254 733 411 085
E-mail: doctor@otedoamos.com